首页> 外文期刊>BMC Anesthesiology >A randomized, placebo controlled, trial of preoperative sustained release Betamethasone plus non-controlled intraoperative Ketorolac or Fentanyl on pain after diagnostic laparoscopy or laparoscopic tubal ligation [ISRCTN52633712]
【24h】

A randomized, placebo controlled, trial of preoperative sustained release Betamethasone plus non-controlled intraoperative Ketorolac or Fentanyl on pain after diagnostic laparoscopy or laparoscopic tubal ligation [ISRCTN52633712]

机译:术前持续释放倍他米松加非控制性术中酮咯酸或芬太尼在诊断性腹腔镜或腹腔镜输卵管结扎术后疼痛的随机,安慰剂对照试验[ISRCTN52633712]

获取原文
           

摘要

Background Gynecological laparoscopic surgery procedures are often complicated by postoperative pain resulting in an unpleasant experience for the patient, delayed discharge, and increased cost. Glucocorticosteroids have been suggested to reduce the severity and incidence of postoperative pain. Methods This study examines the efficacy of a sustained release betamethasone preparation to reduce postoperative pain and the requirement for pain relief drugs after either diagnostic laparoscopy or tubal ligation. Patients were recruited, as presenting, after obtaining informed consent. Prior to surgery, patients were randomly selected by a computer generated table to receive either pharmacy-coded betamethasone (12 mg IM Celestone?) or an optically identical placebo injection of Intralipid? and isotonic saline mixture. The effect of non-controlled prophylactic intraoperative treatment with either fentanyl or ketorolac per surgeon's orders was also noted in this study. Blood samples taken at recovery and at discharge times were extracted and analyzed for circulating betamethasone. Visual analog scale data on pain was gathered at six post-recovery time points in a triple blind fashion and statistically compared. The postoperative requirement for pain relief drugs was also examined. Results Although the injection achieved a sustained therapeutic concentration, no beneficial effect of IM betamethasone on postoperative pain or reduction in pain relief drugs was observed during the postoperative period. Indeed, the mean combined pain scores during the 2 hour postoperative period, adjusted for postoperative opioids as the major confounding factor, were higher approaching statistical significance (P = 0.056) in the treatment group. Higher pain scores were also observed for the tubal ligation patients relative to diagnostic laparoscopy. Intraoperative fentanyl treatment did not significantly lower the average pain score during the 2 hour postoperative period. Intraoperative ketorolac treatment significantly lowered (P = 0.027) pain scores and reduced the postoperative requirement for additional pain relief drugs. Conclusions There was a lack of efficacy of preoperative sustained release betamethasone in reducing postoperative pain despite maintaining a therapeutic concentration during the postoperative period. Intraoperative Ketorolac did afford some short-term pain relief in the postoperative period and reduced the need for additional pain relief drugs.
机译:背景技术妇科腹腔镜手术程序通常会因术后疼痛而变得复杂,导致患者不愉快的经历,延迟出院并增加成本。有人建议使用糖皮质激素来减轻术后疼痛的严重程度和发生率。方法本研究研究了缓释倍他米松制剂减轻术后腹痛的功效以及诊断性腹腔镜或输卵管结扎后对缓解疼痛药物的需求。获得知情同意后,招募患者作为研究对象。手术前,通过计算机生成的表格随机选择患者,以接受药房编码的倍他米松(12 mg IM Celestone?)或光学上相同的安慰剂注射Intralipid ??和等渗盐水混合物。在这项研究中,还指出了根据外科医生的命令使用芬太尼或酮咯酸进行非控制性预防性术中治疗的效果。提取恢复时和出院时采集的血样并分析其倍他米松的循环。在恢复后的六个时间点以三盲方式收集有关疼痛的视觉模拟量表数据,并进行统计比较。还检查了缓解疼痛药物的术后需求。结果尽管注射液达到了持续的治疗浓度,但在术后期间未观察到IM倍他米松对术后疼痛或减轻疼痛的药物的有益作用。的确,在治疗组中,术后2小时的平均综合疼痛评分(以术后阿片类药物为主要混杂因素进行校正)在统计学上具有较高的统计学意义(P = 0.056)。与诊断性腹腔镜检查相比,输卵管结扎患者的疼痛评分更高。术中芬太尼治疗在术后2小时内并未显着降低平均疼痛评分。术中酮咯酸治疗显着降低了(P = 0.027)疼痛评分,并减少了术后对其他镇痛药物的需求。结论术前持续释放倍他米松尽管在术后期间保持了治疗浓度,但仍缺乏减轻术后疼痛的功效。术中酮咯酸确实在术后提供了短期的疼痛缓解,并减少了对其他疼痛缓解药物的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号